Skip to main content
. 2019 Jun 24;30(7):1271–1281. doi: 10.1681/ASN.2018101036

Table 2.

Distribution of urine protein-to-creatinine ratio measurements overall and relative to AKI episodes

Total, n=2048
AKI during Follow-Up, n=324 Non-AKI during Follow-Up, n=1724
No. of urine protein-to-creatinine ratio measurements overall
Mean (±SD) no. of urine protein-to-creatinine ratio measurements 6 (±3) 5 (±3)
Median [interquartile range] number of urine protein-to-creatinine ratio measurements 5 [4–7] 5 [3–7]
Urine protein-to-creatinine ratio measurements relative to AKI episode
Number of urine protein-to-creatinine ratio measurements pre-AKI
 Mean (±SD) 3 (±2)
 Median [interquartile range] 2 [1–3]
Time between last pre-AKI urine protein-to-creatinine ratio and AKI episode
 Mean (±SD) days 199 (±131)
 Median [interquartile range] days 190 [100–283]
No. of urine protein-to-creatinine ratio measurements post-AKI
 Mean (±SD) 3 (±2)
 Median [interquartile range] 2 [1–3]
Time between AKI episode and first post-AKI urine protein-to-creatinine ratio
 Mean (±SD) days 194 (±138)
 Median [interquartile range] days 170 [96–265]